Evidence map›Paper›PMID 26676252›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity.

Ambrose A Dunn-Meynell, Christelle Le Foll, Miranda D Johnson, Thomas A Lutz, Matthew R Hayes, Barry E Levin

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mediators of Amylin Action in Metabolic Control.Journal of clinical medicine · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Ambrose A Dunn-MeynellNeurology Service, Veterans Administration Medical Center, East Orange, New Jersey;
Christelle Le FollInstitute of Veterinary Physiology, University of Zurich, Zurich, Switzerland;
Miranda D JohnsonDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Thomas A LutzInstitute of Veterinary Physiology, University of Zurich, Zurich, Switzerland;
Matthew R HayesTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and.
Barry E LevinNeurology Service, Veterans Administration Medical Center, East Orange, New Jersey; Department of Neurology, Rutgers, New Jersey Medical School, Newark, New Jersey levin@njms.rutgers.edu.
University of Zurich · CHJohns Hopkins Medicine · USRutgers New Jersey Medical SchoolUniversity of Pennsylvania · USVeterans Biomedical Research Institute · US

Funding

SYMPATHO-ADRENAL-INSULIN INTERACTIONS IN OBESITYR01DK030066 · NIDDK · VETERANS BIOMEDICAL RESEARCH INSTITUTE · PI LEVIN, BARRY E · 1986 to 2015
$4.0M
Neuroendocrinology of Energy Balance ControlR01DK096139 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HAYES, MATTHEW R · 2012 to 2016
$1.7M
NIDDK NIH HHS DK-096139NIDDK NIH HHS DK-RO1-30066NIDDK NIH HHS R01 DK096139
6 · The paper itself

Abstract

Amylin enhances arcuate (ARC) and ventromedial (VMN) hypothalamic nuclei leptin signaling and synergistically reduces food intake and body weight in selectively bred diet-induced obese (DIO) rats. Since DIO (125)I-amylin dorsomedial nucleus-dorsomedial VMN binding was reduced, we postulated that this contributed to DIO ventromedial hypothalamus (VMH) leptin resistance, and that impairing VMH (ARC + VMN) calcitonin receptor (CTR)-mediated signaling by injecting adeno-associated virus (AAV) expressing a short hairpin portion of the CTR mRNA would predispose diet-resistant (DR) rats to obesity on high-fat (45%) diet (HFD). Depleting VMH CTR by 80-90% in 4-wk-old male DR rats reduced their ARC and VMN (125)I-labeled leptin binding by 57 and 51%, respectively, and VMN leptin-induced phospho-signal transducer and activator of transcription 3-positive neurons by 59% vs. AAV control rats. After 6 wk on chow, VMH CTR-depleted DR rats ate and gained the equivalent amount of food and weight but had 18% heavier fat pads (relative to carcass weight), 144% higher leptin levels, and were insulin resistant compared with control AAV DR rats. After 6 wk more on HFD, VMH CTR-depleted DR rats ate the same amount but gained 28% more weight, had 60% more carcass fat, 254% higher leptin levels, and 132% higher insulin areas under the curve during an oral glucose tolerance test than control DR rats. Therefore, impairing endogenous VMH CTR-mediated signaling reduced leptin signaling and caused DR rats to become more obese and insulin resistant, both on chow and HFD. These results suggest that endogenous VMH amylin signaling is required for full leptin signaling and protection from HFD-induced obesity.

Indexed as

AnimalsArcuate Nucleus of HypothalamusDiet, High-FatEatingGlucose IntoleranceInsulin ResistanceIodine RadioisotopesIslet Amyloid PolypeptideLeptinMaleObesityRadionuclide ImagingRatsReceptors, CalcitoninRNA, Small InterferingSTAT3 Transcription FactorIodine RadioisotopesIslet Amyloid PolypeptideLeptinReceptors, CalcitoninRNA, Small InterferingStat3 protein, ratSTAT3 Transcription Factorarcuate nucleuscalcitonin receptorinsulin resistancepSTAT3ventromedial nucleus

Identifiers

PMID26676252
PMCPMC4868368
OpenAlexW2261147929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.